GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Other Income (Expense)

Curocell (XKRX:372320) Other Income (Expense) : ₩60.39 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Other Income (Expense)?

Curocell's other income expense for the Curocell's pretax income for the three months ended in Mar. 2025 was ₩21.60 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩60.39 Mil.

Curocell Other Income (Expense) Historical Data

The historical data trend for Curocell's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Other Income (Expense) Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial -812.68 -38,410.50 -18,195.37 3,279.28 50.83

Curocell Quarterly Data
Dec19 Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.75 15.39 11.70 11.69 21.60

Curocell Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩60.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curocell  (XKRX:372320) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Curocell Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Other Income (Expense)
Comparable Companies
XKRX:064550 XKRX:115180 XKRX:215600 XKRX:475960 XKRX:397030 XKRX:389650 XKRX:228760 XKRX:334970 XKRX:078160 XKRX:048410 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell Headlines

No Headlines